Remove 2015 Remove Pharmaceutical manufacturing Remove Specialization
article thumbnail

Precision Medicine Needs an Overhaul

PM360

Between 2015 and 2021, over a quarter of the drugs approved by the US Food and Drug Administration (FDA) were associated with specific biomarkers. Longevity, wellness, and specialty concierges specialized in precision medicine are a bright spot that can offer new options, and indeed hope for patients and caregivers.

article thumbnail

Building CO2-neutral, defossilised supply chains for chemicals

European Pharmaceutical Review

2 However, most of these efforts relating to catalysis, 3 process waste metrics, 4 lifecycle assessments, 5 pharmaceuticals in the environment 6 and the phase out of substances of concern 7 mainly mitigate the consequences of pharmaceutical manufacturing. In 2015 he joined the Process Chemistry & Catalysis group at F.